<?xml version="1.0" encoding="UTF-8"?>
<ref id="B208-microorganisms-07-00133">
 <label>208.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ramsauer</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Schwameis</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Firbas</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Müllner</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Putnak</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Desprès</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tauber</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Jilma</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Tangy</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: A randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial</article-title>
  <source>Lancet Infect. Dis.</source>
  <year>2015</year>
  <volume>15</volume>
  <fpage>519</fpage>
  <lpage>527</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(15)70043-5</pub-id>
  <pub-id pub-id-type="pmid">25739878</pub-id>
 </element-citation>
</ref>
